Table 1: Patient’s demographic data, blood test result, and success of LCLs generation.

Sample annotationAgeGenderEthnicAnti-CCP (IU/mL)RF
(IU/mL)
ESR (mm/hr)CRP (mg/L)DAS28-CRPDisease activityLCL generation

1B71FemaleChinese269.770114.92.02RemissionYes
2C60MaleIndian58.8156681.45.96HighYes
4E66FemaleChinese91.2143124.32.09RemissionNo
5B77FemaleChinese25669412.12.54RemissionYes
6A64FemaleChinese515.71014412.14.19ModerateYes
7B54FemaleChinese163044215.13.92ModerateYes
8A50MaleChinese249.3684615.26.59HighYes
9D69MaleChinese225640953.7--Yes
10E70FemaleChinese2.9154223.7--Yes
11A38FemaleChinese60.717161.44.22ModerateYes
12A63FemaleMalay<0.5<1074775.99HighYes
13B50FemaleChinese179.7462818.34.63ModerateYes
14A36FemaleIndian64.183.46613.63.81ModerateNo
15A55MaleChinese849.21371023.41ModerateYes
16A62FemaleChinese849.2137720.84.49ModerateYes
17A36FemaleChinese2.6551813.84.47ModerateYes
C29MaleChinese------Yes

Anti-CCP: anti-cyclic citrullinated peptide antibody; CRP: C-reactive protein; DAS28: disease activity score 28; ESR: erythrocyte sedimentation rate; RF: rheumatoid factor.